Royal Bank of Canada’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-36,896
Closed -$377K 7647
2022
Q4
$377K Sell
36,896
-4,466
-11% -$45.1K ﹤0.01% 4362
2022
Q3
$413K Sell
41,362
-500
-1% -$4.97K ﹤0.01% 4187
2022
Q2
$413K Buy
41,862
+5,350
+15% +$52.8K ﹤0.01% 4249
2022
Q1
$359K Buy
36,512
+1,012
+3% +$9.94K ﹤0.01% 4554
2021
Q4
$348K Buy
+35,500
New +$347K ﹤0.01% 4804

Other funds holding PEPL

Royal Bank of Canada's PEPL Position: Q1 2023 in Review

Royal Bank of Canada sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2023, closing a stake of 36,896 shares — an estimated $377K sold.

Royal Bank of Canada first reported a position in PEPL in Q4 2021 and held it in 5 quarters. The position peaked at $413K in Q3 2022. 15 funds tracked by Wall St. Rank hold PEPL as of Q1 2023.

  • Royal Bank of Canada reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 36,896 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2023, an estimated $377K.
  • Royal Bank of Canada first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
  • Royal Bank of Canada's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $413K in Q3 2022.
  • 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2023.

Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.